Claudia De Angelis

4PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 27, 2026
Metabolomics Plasma Biomarkers Associated with the HRD Phenotype in Ovarian Cancer.

Alessandro Tubita, Claudia De Angelis, Daniela Grasso

|Apr 09, 2024
Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.

Mariana Brandão, Diogo Martins-Branco, Claudia De Angelis

|Oct 25, 2023
Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.

Mariana Brandão, Diogo Martins-Branco, Claudia De Angelis

|Mar 31, 2021
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).

Claudio Vernieri, Federico Nichetti, Luca Lalli

Pageof 1